4.6 Article

Potential role of increased matrix metalloproteinase-2 (MMP2) transcription in impaired adipogenesis in type 2 diabetes mellitus

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2007.12.180

Keywords

obesity; type 2 diabetes; adipocyte; fatty acid binding protein aP2; matrix metalloproteinase

Funding

  1. NCRR NIH HHS [M01 RR000056, MO1-RR000056] Funding Source: Medline
  2. NIDDK NIH HHS [P30 DK063608, P30 DK63608, DK60412, P30 DK046204, P30 DK072476, R01 DK060412, P3-DK46204, P30 DK072476-04] Funding Source: Medline

Ask authors/readers for more resources

We measured gene expression of paracrine regulators involved in adipocyte differentiation within the stromovascular fraction of abdominal subcutaneous adipose tissue from obese individuals with (n = 30) and without (n = 18) type 2 diabetes mellitus (T2DM). Despite similar adiposity by design, subjects with T2DM had larger adipocytes (0.92 +/- 0.28 vs. 0.75 +/- 0.17 mu l, p < 0.05) than controls. Gene expression of the adipogenic marker aP2 was lower (0.35 +/- 0.16 vs. 0.58 +/- 0.27 arbitrary units, p < 0.05) whereas the expression of matricellular peptidase, MMP2 was higher (1.65 +/- 10.17 vs. 1.27 +/- 0.21, p = 0.02) in T2DM vs. controls. The gene expression levels between the aP2 and MMP2 were inversely correlated (r = -0.32, p = 0.03). We conclude that early steps of adipogenesis may be impaired in T2DM independently of obesity due, in part, to an upregulation of the MMP2 transcription. (c) 2008 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available